Past Symposiums

Drug-induced Pulmonary Hypertension Symposium:
Applying Lessons Learned from The Aminorex Epidemic

April 13-14, 2023, 2nd Meeting of the International Collaborative

The rationale for this symposium is to leverage subject-matter expertise from international academic centers and Stanford University, engage the broader academic communities, global organizations (World Health Organization, United States Food and Drug Administration, European Medicines Agency), and stake-holders (patients, industry partners, etc) to develop a deeper understanding of “drug induced pulmonary hypertension” and establish pharmacovigilance protocols for monitoring drug safety and rapid identification of PH in at-risk populations.

Proteomic & Genomic Deep Phenotyping in Pulmonary Arterial Hypertension

May 13, 2016, A one-day workshop immediately preceding the American Thoracic Society Annual Meeting in San Francisco

Immunity and the Pathogenesis of Pulmonary Arterial Hypertension

November 6, 2015, A one-day workshop immediately preceding the American College of Rheumatology Annual Meeting in San Francisco

BMPR2 in Pulmonary Hypertension: Charting the Future

September 10, 2012, Celebrating the First Decade